Shaping genetic alterations in human cancer: the p53 mutation paradigm.

Université P.M. Curie, 4 place Jussieu, 75005 Paris, France.
Cancer Cell (Impact Factor: 23.89). 11/2007; 12(4):303-12. DOI: 10.1016/j.ccr.2007.10.001
Source: PubMed

ABSTRACT p53 mutations are found in 50% of human cancers. Molecular epidemiology has shown strong correlations between the spectrum of p53 mutations and exposure to exogenous carcinogens. This spectrum is influenced quantitatively and qualitatively by various upstream genetic filters that modulate carcinogen activation, detoxification, and/or DNA repair. In this review, we will discuss how other factors such as tissue specificity, SNP of genes associated with the p53 pathway, other genetic alterations, or p53 mutant heterogeneity can act as a second set of downstream filters that also have a profound impact on the spectrum of p53 mutations.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Bitkilerdeki fenotipik varyasyonların birçoğunun kaynağını genlerdeki nükleotid dizin polimorfizmi oluşturmaktadır. Bu şekilde varyasyonlar, DNA analizine yönelik çeşitli markör tekniklerle (RFLP, CAPs, SSR, AFLP vb.) ortaya konulabilmektedir. Ancak fenotipik varyasyonun ana kaynağını oluşturan, genlerdeki birçok mutasyon şekilleri (nükleotidlerde eklenme, kayıplar, tek nükleotid bazında değişimler) bu yöntemlerle etkin bir şekilde tanımlanamamaktadır. SSCP tekniği orijinal olarak mutasyonların hızlı analizi için geliştirilmiştir. Mutasyonların analizinde; “SSCP (single strand conformation polymorphism)” markörler oldukça hassas ve doğru sonuçlar vermesi nedeniyle avantaj sağlamaktadır. Özellikle son yıllarda genetik çalışmalarda mutasyon, farklı bir yönde ele alınmaya başlanmıştır. Genomda mutasyona uğrayan bölgelerin moleküler olarak belirlenmesi bitkisel araştırmalarda önemli yer tutmaktadır. Yapılan çalışmalarla bitkilerde mutasyonların mekanizması anlaşılmaya çalışılmıştır.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The oxidative stress effect of exercise training on testis function is under debate. In the present study we used a unique rat model system developed by artificial selection for low and high intrinsic running capacity (LCR and HCR, respectively) to evaluate the effects of exercise training on apoptosis and spermatogenesis in testis. Twenty-four 13-month-old male rats were assigned to four groups: control LCR (LCR-C), trained LCR (LCR-T), control HCR (HCR-C), and trained HCR (HCR-T). Ten key proteins connecting aerobic exercise capacity and general testes function were assessed, including those that are vital for mitochondrial biogenesis. The VO2 max of LCR-C group was about 30% lower than that of HCR-C rats, and the SIRT1 levels were also significantly lower than HCR-C. Twelve weeks of training significantly increased maximal oxygen consumption in LCR by nearly 40% whereas HCR remained unchanged. LCR-T had significantly higher levels of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1α), decreased levels of reactive oxygen species and increased acetylated p53 compared to LCR-C, while training produced no significant changes for these measures in HCR rats. BAX and Blc-2 were not different among all four groups. The levels of outer dense fibers -1 (Odf-1), a marker of spermatogenesis, increased in LCR-T rats, but decreased in HCR-TR rats. Moreover, exercise training increased the levels of lactate dehydrogenase C (LDHC) only in LCR rats. These data suggest that rats with low inborn exercise capacity can increase whole body oxygen consumption and running exercise capacity with endurance training and, in turn, increase spermatogenesis function via reduction in ROS and heightened activity of p53 in testes.
    PLoS ONE 12/2014; 9(12):e114075. DOI:10.1371/journal.pone.0114075 · 3.53 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Diverse array of therapeutic regimens, drugs or siRNA, are commonly used to regress cardiac hypertrophy, although, bystander effect and lower retention of bioactive molecules significantly reduce their functional clinical efficacy. Carvedilol, a widely used and effective anti-hypertrophic drug, simultaneously blocks β-adrenergic receptors non-specifically in various organs. Likewise, non-specific genome-wide downregulation of p53 expression by specific siRNA efficiently abrogates cardiac hypertrophy but results in extensive tumorigenesis affecting bystander organs. Therefore, delivery of such therapeutics had been a challenge in treating cardiovascular dysfunction. Cardiac tissue engineering was successfully accomplished in this study, by encapsulating such bioactive molecules with a stearic acid modified Carboxymethyl chitosan (CMC) nanopolymer conjugated to a homing peptide for delivery to hypertrophied cardiomyocytes in vivo. The peptide precisely targeted cardiomyocytes while CMC served as the vector mediator to pathological myocardium. Controlled delivery of active therapeutic payloads within cardiomyocytes resulted in effective regression of cardiac hypertrophy. Thus, this novel nano-construct as a spatio-temporal vector would be a potential tool for developing effective therapeutic strategies within cardiac micro-environment via targeted knockdown of causal genes.
    Journal of Controlled Release 01/2015; 200C(2015). DOI:10.1016/j.jconrel.2015.01.008 · 7.63 Impact Factor

Full-text (2 Sources)

Available from
May 16, 2014